48 results on '"Boguszewski MC"'
Search Results
2. Association of Cardiorespiratory Fitness and Abdominal Obesity in Full Time Students from Countryside
- Author
-
Cat Cat Mn, Leite Leite N, Brito Brito Lm, and Boguszewski Mc
- Subjects
Gerontology ,Full-time ,business.industry ,Medicine ,Physical Therapy, Sports Therapy and Rehabilitation ,Orthopedics and Sports Medicine ,Cardiorespiratory fitness ,Rural area ,medicine.symptom ,Association (psychology) ,business ,Abdominal obesity - Published
- 2016
3. Growth hormone isoforms in newborns and postpartum women
- Author
-
Boguszewski, CL, primary, Boguszewski, MC, additional, de Zegher, F, additional, Carlsson, B, additional, and Carlsson, LM, additional
- Published
- 2000
- Full Text
- View/download PDF
4. Circulating non-22 kDa growth hormone isoforms in healthy children of normal stature: relation to height, body mass and pubertal development
- Author
-
Boguszewski, CL, primary, Jansson, C, additional, Boguszewski, MC, additional, Rosberg, S, additional, Wikland, KA, additional, Carlsson, B, additional, and Carlsson, LM, additional
- Published
- 1997
- Full Text
- View/download PDF
5. Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype
- Author
-
M E, Street, C, Spaggiari, M A, Ziveri, M, Rossi, C, Volta, I, Viani, G L, Grzincich, C, Sartori, M, Zanzucchi, V, Raia, C, Terzi, G, Pisi, E, Zanetti, M C S, Boguszewski, T O, Kamoi, S, Bernasconi, Street, Me, Spaggiari, C, Ziveri, Ma, Rossi, M, Volta, C, Viani, I, Grzincich, Gl, Sartori, C, Zanzucchi, M, Raia, Valeria, Terzi, C, Pisi, G, Zanetti, E, Boguszewski, Mc, Kamoi, To, and Bernasconi, S.
- Subjects
Adult ,Inflammation ,Male ,Adolescent ,C-Peptide ,Cystic Fibrosis ,Genotype ,Age Factors ,Glucose Tolerance Test ,Body Mass Index ,Young Adult ,Insulin-Secreting Cells ,Homeostasis ,Humans ,Insulin ,Female ,Insulin Resistance ,Child ,Lung - Abstract
AIM: To assess the major determinants of glucose tolerance between age, genotype, and clinical status in cystic fibrosis (CF) patients, and study if defects of insulin secretion and insulin sensitivity were associated with the onset of CF-related diabetes (CFRD). SUBJECTS AND METHODS: One hundred and nineteen patients, in stable clinical condition were studied. They were subdivided into 3 groups based on age, and 2 groups based on Schwachman-Kulczycki clinical score. All patients were genotyped, and subsequently divided into 3 groups. Ninety-four healthy normal-weight controls, comparable for sex and age were also studied. All subjects had baseline blood samples taken for glucose and insulin, C-peptide, and glycated hemoglobin. Homeostasis model assessment of insulin resistance (HOMA-IR), fasting glucose/insulin ratio (FGIR) were calculated as indices of IR and insulinogenic index as a marker of pancreatic β-cell function. All patients underwent an oral glucose tolerance test, and 57 underwent an IVGTT for the calculation of first-phase (FPIR) and acute insulin responses (AIR). RESULTS: The F508del homozygous patients had an increased chance of developing impaired glucose tolerance (IGT) and significantly lower FPIR, decreased HOMA-IR, and insulinogenic index. Heterozygote F508del patients had an increased chance of having normal glucose tolerance. HOMA-IR, FGIR, and insulinogenic index did not change with age or clinical score. HOMAIR correlated with FPIR. FPIR correlated positively with insulinogenic index. AIR correlated negatively with FGIR, and positively with C-reactive protein. In multiple linear regression analyses, glucose tolerance was related to the agegroup, and to the HOMA-IR and insulinogenic indexes. CONCLUSIONS: IGT and CFRD were related mainly to genotype, although, as expected, the prevalence increased with age. The data suggested a possible combined contribution of insulin deficiency, β-cell function, and reduced insulin sensitivity to the onset of CFRD; however, further studies are warranted to better elucidate this aspect.
- Published
- 2012
6. EndoBridge 2023: highlights and pearls.
- Author
-
Yildiz BO, Boguszewski CL, da Silva Boguszewski MC, Busetto L, Celik O, Fuleihan GE, Goulis DG, Hammer GD, Haymart MR, Kaltsas G, Law JR, Lim AYL, Luger A, Macut D, McGowan B, McClung M, Miras AD, Patti ME, Peeters RP, Pignatelli D, Saeed H, Sipos J, Stratakis CA, Tsoli M, van der Lely AJ, Witchel SF, and Yazici D
- Subjects
- Humans, Endocrinology history, Osteoporosis therapy, Endocrine System Diseases therapy
- Abstract
EndoBridge 2023 took place on October 20-22, 2023, in Antalya, Turkey. Accredited by the European Council, the 3-day scientific program of the 11
th Annual Meeting of EndoBridge included state-of-the-art lectures and interactive small group discussion sessions incorporating interesting and challenging clinical cases led by globally recognized leaders in the field and was well attended by a highly diverse audience. Following its established format over the years, the program provided a comprehensive update across all aspects of endocrinology and metabolism, including topics in pituitary, thyroid, bone, and adrenal disorders, neuroendocrine tumors, diabetes mellitus, obesity, nutrition, and lipid disorders. As usual, the meeting was held in English with simultaneous translation into Russian, Arabic, and Turkish. The abstracts of clinical cases presented by the delegates during oral and poster sessions have been published in JCEM Case Reports. Herein, we provide a paper on highlights and pearls of the meeting sessions covering a wide range of subjects, from thyroid nodule stratification to secondary osteoporosis and from glycemic challenges in post-bariatric surgery to male hypogonadism. This report emphasizes the latest developments in the field, along with clinical approaches to common endocrine issues. The 12th annual meeting of EndoBridge will be held on October 17-20, 2024 in Antalya, Turkey., (© 2024. The Author(s), under exclusive licence to Hellenic Endocrine Society.)- Published
- 2024
- Full Text
- View/download PDF
7. Growth Hormone Treatment for Short Children Born Small for Gestational Age.
- Author
-
de Andre Cardoso-Demartini A, Malaquias AC, and da Silva Boguszewski MC
- Subjects
- Body Height, Child, Preschool, Female, Gestational Age, Growth Disorders, Humans, Infant, Small for Gestational Age, Pregnancy, Human Growth Hormone therapeutic use, Sexual Maturation
- Abstract
Despite the difficulty to define born small for gestational age (SGA), being SGA has been associated with a higher risk of short stature, early-onset and rapid progression of puberty, neurocognitive dysfunctions, alterations in body composition, bone density, glucose and lipid metabolism and increased risk for cardiovascular diseases later in life. The majority of children born SGA experience spontaneous catch-up growth during the first years of life. For those who remain with short stature, treatment with recombinant human growth hormone (rhGH) may be initiated, preferably after 2-4 years of age. Response to treatment is variable. However, the benefits of rhGH go beyond increase in stature as the therapy may also improve body composition. In this review we will cover the indication and effects of GH therapy in short children born SGA., (Copyright© of YS Medical Media ltd.)
- Published
- 2018
- Full Text
- View/download PDF
8. Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.
- Author
-
Christiansen JS, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, Casanueva FF, Chanson P, Chatelain P, Choong CS, Clemmons DR, Cohen LE, Cohen P, Frystyk J, Grimberg A, Hasegawa Y, Haymond MW, Ho K, Hoffman AR, Holly JM, Horikawa R, Höybye C, Jorgensen JO, Johannsson G, Juul A, Katznelson L, Kopchick JJ, Lee KO, Lee KW, Luo X, Melmed S, Miller BS, Misra M, Popovic V, Rosenfeld RG, Ross J, Ross RJ, Saenger P, Strasburger CJ, Thorner MO, Werner H, and Yuen K
- Subjects
- Clinical Trials as Topic, Consensus, Hormone Replacement Therapy adverse effects, Human Growth Hormone adverse effects, Humans, Research Design, Dwarfism, Pituitary drug therapy, Hormone Replacement Therapy methods, Human Growth Hormone therapeutic use
- Abstract
Objective: The Growth Hormone (GH) Research Society (GRS) convened a workshop to address important issues regarding trial design, efficacy, and safety of long-acting growth hormone preparations (LAGH)., Participants: A closed meeting of 55 international scientists with expertise in GH, including pediatric and adult endocrinologists, basic scientists, regulatory scientists, and participants from the pharmaceutical industry., Evidence: Current literature was reviewed for gaps in knowledge. Expert opinion was used to suggest studies required to address potential safety and efficacy issues., Consensus Process: Following plenary presentations summarizing the literature, breakout groups discussed questions framed by the planning committee. Attendees reconvened after each breakout session to share group reports. A writing team compiled the breakout session reports into a draft document that was discussed and revised in an open forum on the concluding day. This was edited further and then circulated to attendees from academic institutions for review after the meeting. Participants from pharmaceutical companies did not participate in the planning, writing, or in the discussions and text revision on the final day of the workshop. Scientists from industry and regulatory agencies reviewed the manuscript to identify any factual errors., Conclusions: LAGH compounds may represent an advance over daily GH injections because of increased convenience and differing phamacodynamic properties, providing the potential for improved adherence and outcomes. Better methods to assess adherence must be developed and validated. Long-term surveillance registries that include assessment of efficacy, cost-benefit, disease burden, quality of life, and safety are essential for understanding the impact of sustained exposure to LAGH preparations., (© 2016 The authors.)
- Published
- 2016
- Full Text
- View/download PDF
9. Growth hormone, insulin-like growth factor system and carcinogenesis.
- Author
-
Boguszewski CL, Boguszewski MC, and Kopchick JJ
- Subjects
- Female, Humans, Male, Carcinogenesis metabolism, Growth Hormone, Insulin-Like Growth Factor I, Signal Transduction
- Abstract
The growth hormone (GH) and insulin-like growth factor (IGF) system plays an important role in the regulation of cell proliferation, differentiation, apoptosis, and angiogenesis. In terms of cell cycle regulation, the GH-IGF system induces signalling pathways for cell growth that compete with other signalling systems that result in cell death; thus the final effect of these opposed forces is critical for normal and abnormal cell growth. The association of the GH-IGF system with carcinogenesis has long been hypothesised, mainly based on in vitro studies and the use of a variety of animal models of human cancer, and also on epidemiological and clinical evidence in humans. While ample experimental evidence supports a role of the GH-IGF system in tumour promotion and progression, with several of its components being currently tested as central targets for cancer therapy, the strength of evidence from patients with acromegaly, GH deficiency, or treated with GH is much weaker. In this review, we will attempt to consolidate this data. (Endokrynol Pol 2016; 67 (4): 414-426).
- Published
- 2016
- Full Text
- View/download PDF
10. The influence of glycemic control on the oral health of children and adolescents with diabetes mellitus type 1.
- Author
-
Carneiro VL, Fraiz FC, Ferreira Fde M, Pintarelli TP, Oliveira AC, and Boguszewski MC
- Subjects
- Adolescent, Child, Child, Preschool, Cross-Sectional Studies, Dental Caries, Dental Health Surveys, Diabetes Mellitus, Type 1 prevention & control, Female, Gingival Hemorrhage, Humans, Male, Quality of Life, Sex Factors, Statistics, Nonparametric, Blood Glucose analysis, Diabetes Mellitus, Type 1 blood, Glycated Hemoglobin analysis, Oral Health, Salivation physiology
- Abstract
Objective: To evaluate the influence of disease control, expressed by the mean values of glycated hemoglobin (HbA1c), in the oral health of children and adolescents with diabetes mellitus type 1 (T1DM)., Subjects and Methods: A cross sectional study involving 87 children and adolescents (59 girls), 10 ± 2.6 years old. The participants were divided into three groups: HbA1c ≤ 8%, 8% < HbA1c ≤ 10% and HbA1c > 10%. The duration of the disease, age and average HbA1c were obtained from their medical records. Oral health was evaluated according to the following indexes: Simplified Oral Hygiene Index (OHI-S); Community Periodontal Index (CPI); Decayed, Missing or Filled Teeth Index (DMFT/dmft) for permanent and deciduous teeth; and the stimulated salivary flow rate (SSFR)., Results: The median SSFR was 1.1 mL/min in the group with HbA1c ≤ 8%, 0.7 mL/min in the intermediary group and 0.6 mL/min in the HbA1c > 10% group. A significant decrease in salivary flow was observed with an increase in HbA1c (p = 0.007). The DMFT/dmft and CPI indexes were higher in individuals with higher HbA1c values. More caries-free individuals were found in the group with HbA1c ≤ 8% compared to those with HbA1c > 10%. The group with HbA1c > 10% exhibited more caries and bleeding gums than the other groups. HbA1c values in girls were higher than in boys., Conclusion: Children and adolescents with unsatisfactory glycemic control, represented by higher HbA1c concentrations, exhibited a higher frequency of caries and gingivitis, and a reduction in salivary flow.
- Published
- 2015
- Full Text
- View/download PDF
11. Metabolic risk and television time in adolescent females.
- Author
-
Machado-Rodrigues AM, Leite N, Coelho-e-Silva MJ, Enes F, Fernandes R, Mascarenhas LP, Boguszewski MC, and Malina RM
- Subjects
- Adolescent, Anthropometry, Blood Chemical Analysis, Blood Pressure Determination, Brazil, Cluster Analysis, Cross-Sectional Studies, Female, Health Promotion organization & administration, Humans, Metabolic Syndrome physiopathology, Obesity epidemiology, Obesity physiopathology, Parents education, Predictive Value of Tests, Risk Assessment, Time Factors, Metabolic Syndrome etiology, Motor Activity physiology, Sedentary Behavior, Television statistics & numerical data
- Abstract
Objectives: A sedentary lifestyle is increasingly implicated in a negative metabolic health profile among youth. The present study examined relationships between clustered metabolic risk factors and TV viewing in female adolescents., Methods: The sample comprised 262 girls 14-17 years. Height, weight, fasting glucose, insulin, HDL cholesterol, triglycerides, and blood pressure were measured. Body mass index (BMI) was calculated. TV viewing time and moderate-to-vigorous physical activity (MVPA) were estimated from a 3-day diary. Outcome variables were normalized and expressed as Z scores which were summed into a metabolic risk score. Multiple linear regression analysis was used., Results: TV viewing was independently associated with increased prevalence of clustered metabolic risk in girls after adjustment for several confounders (i.e., chronological age, BMI, MVPA, and parental education). The final model also indicated that lower levels of MVPA, higher BMI, and lower mother education were associated with higher metabolic risk., Conclusions: Increased TV viewing had an adverse effect on metabolic health of adolescent girls. The findings highlight the potential importance of preventive actions to ameliorate metabolic risk in youth which target both sedentary and physically active behaviors.
- Published
- 2015
- Full Text
- View/download PDF
12. Variability of lipid and lipoprotein concentrations during puberty in Brazilian boys.
- Author
-
Mascarenhas LP, Leite N, Titski AC, Brito LM, and Boguszewski MC
- Subjects
- Adolescent, Body Weights and Measures, Brazil epidemiology, Child, Cholesterol, HDL blood, Cholesterol, LDL blood, Humans, Male, Triglycerides blood, Lipids blood, Lipoproteins blood, Puberty blood
- Abstract
Background: Evaluation of lipid profile in children and adolescents is important for early diagnosis of dyslipidemias. Physiological changes might be observed in the concentration of the lipid profile components, according to the stage of sexual maturation., Objective: To evaluate the variation in lipid and lipoprotein concentrations in boys during puberty., Methods: The sample consisted of 570 male adolescents with ages between 10 and 17 years. Weight, height, and body mass index (BMI) were assessed. Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG) were determined by the enzymatic method, and low-density lipoprotein cholesterol (LDL-C) was calculated. Puberty was classified according to Tanner references. The percentile criterion was adopted for the distribution and identification of lipoprotein levels. The analysis of variance and description tests with p<0.05 was applied., Results: Participants had similar BMI z-score and physical activity habits in all groups. A significant reduction in TC and HDL-C concentrations between the start and end of puberty was observed. LDL-C levels rose during stage 3 of development, decreasing at the end of the pubertal process. TG levels did not change significantly with pubertal status., Conclusion: Lipid and lipoprotein concentrations tend to undergo changes during puberty in boys. The use of percentile values can be very useful to track variations in lipid and lipoprotein levels during the maturation process.
- Published
- 2015
- Full Text
- View/download PDF
13. Relationship between metabolic syndrome and moderate-to-vigorous physical activity in youth.
- Author
-
Machado-Rodrigues AM, Leite N, Coelho e Silva MJ, Valente-dos-Santos J, Martins RA, Mascarenhas LP, Boguszewski MC, Padez C, and Malina RM
- Subjects
- Adolescent, Blood Glucose, Blood Pressure, Body Size, Brazil, Cholesterol, HDL blood, Cross-Sectional Studies, Exercise Test, Female, Humans, Life Style, Male, Physical Examination, Risk, Risk Factors, Triglycerides blood, Exercise physiology, Metabolic Syndrome physiopathology, Motor Activity physiology, Physical Fitness physiology
- Abstract
Background: Associations of metabolic syndrome (MetS) with lifestyle behaviors in youth is potentially important for identifying subgroups at risk and encourage interventions. This study evaluates the associations among the clustering of metabolic risk factors and moderate-to-vigorous physical activity (MVPA) in youth., Methods: The sample comprised 522 girls and 402 boys (N = 924) aged 11 to 17 years. Height, weight, waist circumference (WC), fasting glucose, high-density lipoprotein cholesterol, triglycerides, and blood pressures were measured. Cardiorespiratory fitness (CRF) was assessed using the 20-m shuttle run test. MVPA was estimated with a 3-day diary. Outcome variables were statistically normalized and expressed as z scores. A clustered metabolic risk score was computed as the mean of z scores. Multiple linear regression was used to test associations between metabolic risk and MVPA by sex, adjusted for age, WC, and CRF., Results: After adjustment for potential confounders, MVPA was inversely associated with the clustering of metabolic risk factors in girls, but not in boys; in addition, after adjusting for WC, the statistical model of that relationship was substantially improved in girls., Conclusion: MVPA was independently associated with increased risk of MetS in girls. Additional efforts are needed to encourage research with different analytical approach and standardization of criteria for MetS in youth.
- Published
- 2015
- Full Text
- View/download PDF
14. Whole exome sequencing of extreme morbid obesity patients: translational implications for obesity and related disorders.
- Author
-
Paz-Filho G, Boguszewski MC, Mastronardi CA, Patel HR, Johar AS, Chuah A, Huttley GA, Boguszewski CL, Wong ML, Arcos-Burgos M, and Licinio J
- Abstract
Whole-exome sequencing (WES) is a new tool that allows the rapid, inexpensive and accurate exploration of Mendelian and complex diseases, such as obesity. To identify sequence variants associated with obesity, we performed WES of family trios of one male teenager and one female child with severe early-onset obesity. Additionally, the teenager patient had hypopituitarism and hyperprolactinaemia. A comprehensive bioinformatics analysis found de novo and compound heterozygote sequence variants with a damaging effect on genes previously associated with obesity in mice (LRP2) and humans (UCP2), among other intriguing mutations affecting ciliary function (DNAAF1). A gene ontology and pathway analysis of genes harbouring mutations resulted in the significant identification of overrepresented pathways related to ATP/ITP (adenosine/inosine triphosphate) metabolism and, in general, to the regulation of lipid metabolism. We discuss the clinical and physiological consequences of these mutations and the importance of these findings for either the clinical assessment or eventual treatment of morbid obesity.
- Published
- 2014
- Full Text
- View/download PDF
15. Three-year growth response to growth hormone treatment in very young children born small for gestational age-data from KIGS.
- Author
-
Boguszewski MC, Lindberg A, and Wollmann HA
- Subjects
- Child, Child, Preschool, Databases, Factual, Female, Follow-Up Studies, Growth Disorders epidemiology, Humans, Infant, Newborn, Male, Treatment Outcome, Child Development drug effects, Growth Disorders drug therapy, Human Growth Hormone therapeutic use, Infant, Small for Gestational Age growth & development
- Abstract
Context: Children born small for gestational age (SGA) with poor growth during the first years of life may remain short in stature during childhood and as adults., Objective: To evaluate the 3-year growth response to GH treatment in very young short children born SGA, and to test the existing predictions models for growth response developed for older SGA children., Setting: KIGS (The Pfizer International Growth Database)., Patients: A total of 620 SGA children (birth length and/or weight below -2 SD score [SDS]) on GH treatment, 156 in the 2- to 4-year-old group (100 boys; median age, 3.3 y), and 464 in the 4- to 6-year-old group (284 boys; median age, 4.9 y)., Results: Median values and 10th-90th percentiles are presented. Both groups presented a significant increase in height velocity during GH treatment. Median height SDS increased from -3.9 (-5.4 to -2.9) at the start to -2.2 (-3.8 to -1.0) at 3 years in the 2- to 4-year-old group (P < .01) and from -3.4 (-4.5 to -2.6) to -2.0 (-3.3 to -0.9) in the 4- to 6-year-old group (P < .01). Median weight SDS increased from -3.8 (-5.9 to -2.4) to -2.1 (-4.1 to -0.5) in the 2- to 4-year-old group (P < .01). Respective values for the 4- to 6-year-old group were -3.1 (-4.8 to -1.8) to -1.6 (-3.1 to -0.1) SDS (P < .01). First- and second-year growth response could be estimated by the SGA model., Conclusion: Very young children born SGA without spontaneous catch-up growth presented a significant improvement in height and weight during the 3 years of GH treatment. Growth response could be estimated by the SGA model.
- Published
- 2014
- Full Text
- View/download PDF
16. Independent association of clustered metabolic risk factors with cardiorespiratory fitness in youth aged 11-17 years.
- Author
-
Machado-Rodrigues AM, Leite N, Coelho-e-Silva MJ, Martins RA, Valente-dos-Santos J, Mascarenhas LP, Boguszewski MC, Padez C, and Malina RM
- Subjects
- Adolescent, Anthropometry, Brazil epidemiology, Child, Cross-Sectional Studies, Exercise Test, Female, Humans, Male, Prevalence, Risk Factors, Metabolic Syndrome epidemiology, Physical Fitness
- Abstract
Background: Although the prevalence of metabolic syndrome (MetS) has increased in youth, the potential independent contribution of cardiorespiratory fitness (CRF) to the clustering of metabolic risk factors has received relatively little attention., Aim: This study evaluated associations between the clustering of metabolic risk factors and CRF in a sample of youth., Subjects and Methods: Height, weight, BMI, fasting glucose, insulin, HDL-cholesterol, triglycerides and blood pressures were measured in a cross-sectional sample of 924 youth (402 males, 522 females) of 11-17 years. CRF was assessed using the 20-metre shuttle run test. Physical activity (PA) was measured with a 3-day diary. Outcome variables were statistically normalized and expressed as Z-scores. A MetS risk score was computed as the mean of the Z-scores. Multiple linear regression was used to test associations between CRF and metabolic risk, adjusted for age, sex, BMI, PA and parental education., Results: CRF was inversely associated with MetS after adjustment for potential confounders. After adjusting for BMI, the relationship between CRF and metabolic risk has substantially improved., Conclusion: CRF was independently associated with the clustering of metabolic risk factors in youth of 11-17 years of age.
- Published
- 2014
- Full Text
- View/download PDF
17. Reappraisal of serum insulin-like growth factor-I (IGF-1) measurement in the detection of isolated and combined growth hormone deficiency (GHD) during the transition period.
- Author
-
Boguszewski CL, Lacerda CS, Lacerda Filho Ld, Carvalho JA, and Boguszewski MC
- Subjects
- Adolescent, Adult, Age Factors, Analysis of Variance, Cross-Sectional Studies, Female, Human Growth Hormone blood, Humans, Insulin metabolism, Male, Pituitary Diseases blood, Pituitary Function Tests, Predictive Value of Tests, Reference Values, Retrospective Studies, Transition to Adult Care, Young Adult, Human Growth Hormone deficiency, Insulin-Like Growth Factor I analysis, Pituitary Diseases diagnosis
- Abstract
Objective: To evaluate the accuracy of serum IGF-1 in the detection of isolated (IGHD) or combined growth hormone deficiency (CGHD) at the transition phase., Subjects and Methods: Forty nine patients with GHD during childhood [16 with IGHD (10 men) and 33 with CGHD (24 men); age 23.2 ± 3.5 yrs.] were submitted to an insulin tolerance test (ITT) with a GH peak < 5 µg/L used for the diagnosis of GHD at the transition phase. Pituitary function and IGF-1 measurements were evaluated in the basal sample of the ITT. Transition patients were reclassified as GH-sufficient (SGH; n = 12), IGHD (n = 7), or CGHD (n = 30)., Results: Five (31%) patients with IGHD and 32 (97%) with CGHD at childhood persisted with GHD at retesting. One patient with IGHD was reclassified as CGHD, whereas 3 patients with CGHD were reclassified as IGHD. Mean GH peak was 0.2 ± 0.3 µg/L in the CGHD, 1.3 ± 1.5 µg/L in the IGHD, and 18.1 ± 13.1 µg/L in the SGH group. Serum IGF-1 level was significantly higher in the SGH (272 ± 107 ng/mL) compared to IGHD (100.2 ± 110) and CGHD (48.7 ± 32.8) (p < 0.01). All patients reclassified as CGHD, 86% reclassified as IGHD, and 8.3% reclassified as SGH had low IGF-1 level, resulting in 97.3% sensitivity and 91.6% specificity in the detection of GHD at the transition period; the cutoff value of 110 ng/mL showed 94.5% sensitivity and 100% specificity. Mean IGF-1 values did not differ in IGHD or CGHD associated with one, two, three, or four additional pituitary deficiencies., Conclusion: IGF-1 measurement is accurate to replace ITT as initial diagnostic test for IGHD and CGHD detection at the transition phase.
- Published
- 2013
- Full Text
- View/download PDF
18. Variations in the vitamin D-binding protein (DBP) gene are related to lower 25-hydroxyvitamin D levels in healthy girls: a cross-sectional study.
- Author
-
Santos BR, Mascarenhas LP, Boguszewski MC, and Spritzer PM
- Subjects
- Adolescent, Brazil, Child, Cross-Sectional Studies, Female, Genotype, Humans, Polymorphism, Genetic, Vitamin D blood, Vitamin D Deficiency blood, Vitamin D Deficiency genetics, Vitamin D-Binding Protein blood, Vitamin D analogs & derivatives, Vitamin D-Binding Protein genetics
- Abstract
Background/aims: Vitamin D deficiency has been recognized as a worldwide epidemic affecting several pediatric and adolescent populations. We determined the genotype and haplotype distribution of the rs4588 and rs7041 polymorphisms of the GC gene encoding vitamin D-binding protein (DBP) and investigated the associations between these gene variants and their haplotypes with 25-hydroxyvitamin D [25(OH)D] levels in girls from South Brazil., Methods: Cross-sectional study including 198 apparently healthy girls aged 10-18 years. Plasma levels of 25(OH)D were assessed by radioimmunoassay. Participants were genotyped for rs4588 and rs7041 by real-time PCR, with allelic discrimination assays., Results: Mean chronological age and BMI percentile were 13.17 ± 1.74 years and 57.81 ± 29.03, respectively. Sufficient circulating 25(OH)D levels (≥30 ng/ml) were found in 9.1% of the overall group, insufficient levels (20-29.9 ng/ml) in 59.6%, and deficient levels (<20 ng/ml) in 31.3%. The AA genotype of rs4588, TT genotype of rs7041 and CT-AT/AT-AT (GC 1f-2/2-2) diplotypes were significantly associated with lower 25(OH)D levels, even after adjustment for age and season at the time of blood collection., Conclusions: The GC gene genotype may be related to the susceptibility to low 25(OH)D levels in female children and adolescents., (Copyright © 2013 S. Karger AG, Basel.)
- Published
- 2013
- Full Text
- View/download PDF
19. Chiari I malformation with neurogenic hypertension: case report.
- Author
-
de Almeida Holanda MM, Ferreira CD, Rocha AB, Santos RH, Neto NG, and Boguszewski MC
- Subjects
- Arnold-Chiari Malformation surgery, Blood Pressure, Brain Stem pathology, Child, Decompression, Surgical, Humans, Hypertension surgery, Magnetic Resonance Imaging, Male, Arnold-Chiari Malformation complications, Hypertension complications
- Published
- 2012
- Full Text
- View/download PDF
20. Vitamin D receptor gene polymorphisms and sex steroid secretion in girls with precocious pubarche in Southern Brazil: a pilot study.
- Author
-
Santos BR, Mascarenhas LP, Satler F, Boguszewski MC, and Spritzer PM
- Subjects
- Brazil, Case-Control Studies, Child, Child, Preschool, DNA analysis, DNA genetics, Female, Genetic Predisposition to Disease, Humans, Pilot Projects, Polycystic Ovary Syndrome metabolism, Polycystic Ovary Syndrome pathology, Polymerase Chain Reaction, Prognosis, Estradiol metabolism, Polycystic Ovary Syndrome etiology, Polymorphism, Single Nucleotide genetics, Puberty, Precocious complications, Receptors, Calcitriol genetics, Testosterone metabolism
- Abstract
Background: Evidence suggests that precocious pubarche (PP) girls may have higher risk of developing polycystic ovary syndrome (PCOS) at later ages. Vitamin D receptor (VDR) gene polymorphisms have been implicated in the risk of diabetes and PCOS, but little is known about the role of VDR in PP., Aim: To assess the frequencies of VDR gene ApaI, TaqI, BsmI, and FokI polymorphisms and to determine whether these variants are associated with sex hormone concentrations in patients with PP and controls from southern Brazil., Subjects and Methods: Blood was collected from 36 girls with PP and 197 controls for genotyping of BsmI and FokI polymorphisms using real-time PCR and of ApaI e TaqI polymorphisms using restriction fragment length polymorphism. Hormone levels were also determined., Results: Genotype GG of the ApaI single nucleotide polymorphism (SNP) was more frequent in PP (30.6%) than in controls (16.2%) [odds ratio (OR): 2.269; confidence interval 95% (95%CI): 1.015-5.076; p=0.042]. This genotype was also associated with lower estradiol [35.30 (14.80-50.48) pg/ml vs 12.22 (6.49-23.69) pg/ml; p=0.025] and total testosterone levels (0.52 (0.39-0.84) ng/ml vs 0.20 (0.11-0.47) ng/ml; p=0.005) as compared with the TT + TG genotypes in girls with PP. The distribution of TaqI, BsmI, and Fokl SNP was similar in PP and controls, and no association was found between these polymorphisms and sex steroid levels., Conclusions: The ApaI SNP of the VDR gene was associated with PP in the studied population and may modulate ovarian steroid secretion in these girls.
- Published
- 2012
- Full Text
- View/download PDF
21. Correlation of cardiorespiratory fitness with risk factors for cardiovascular disease in children with type 1 diabetes mellitus.
- Author
-
Miculis CP, de Campos W, Gasparotto GS, Silva MP, Mascarenhas LP, and Boguszewski MC
- Subjects
- Adolescent, Adolescent Development, Brazil epidemiology, Cardiovascular Diseases complications, Child, Child Development, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 complications, Female, Glycated Hemoglobin analysis, Humans, Hypercholesterolemia complications, Hypertension complications, Lipids blood, Male, Risk Factors, Sex Characteristics, Cardiovascular Diseases epidemiology, Cardiovascular System physiopathology, Diabetes Mellitus, Type 1 physiopathology, Diabetic Cardiomyopathies epidemiology, Physical Fitness, Respiratory System physiopathology
- Abstract
Unlabelled: The objective of this study was to correlate CRF with cardiovascular risk factors in T1DM children., Methods: Fifty children and adolescents aged between 9 and 17 years with no diabetes complications and a mean diabetes duration of 4.6 years were selected. Antropometric, sexual maturation and blood pressure data were evaluated. CRF level was assessed with a 20-m shuttle run test. Laboratory tests were performed to verify fasting lipids and glycated hemoglobin. Statistical analyses were made with Pearson partial correlation, t test, and one-way ANOVA, with p≤0.05., Results: After adjustment for body adiposity and sexual maturity, inverse correlations among CRF and TC, TG, TC/HDL-C, TG/HDL-C, non-HDL-C, and SBP were statistically significant. Variables differing by sex included weight Z score, BMI Z score, skinfold thickness, percentage of body fat, and DBP. Boys had higher CRF compared to girls. CRF and TC differed significantly by sexual maturation status., Conclusion: An inverse and significant relationship between CRF and most lipid profile's components and SBP in poor controlled T1DM children and adolescents was found, independently of body adiposity., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
22. Vitamin D deficiency in girls from South Brazil: a cross-sectional study on prevalence and association with vitamin D receptor gene variants.
- Author
-
Santos BR, Mascarenhas LP, Satler F, Boguszewski MC, and Spritzer PM
- Subjects
- Adolescent, Amplified Fragment Length Polymorphism Analysis, Biomarkers blood, Brazil epidemiology, Child, Cross-Sectional Studies, Female, Genetic Markers, Humans, Linear Models, Odds Ratio, Prevalence, Vitamin D analogs & derivatives, Vitamin D blood, Vitamin D Deficiency blood, Vitamin D Deficiency epidemiology, Haplotypes, Polymorphism, Single Nucleotide, Receptors, Calcitriol genetics, Vitamin D Deficiency genetics
- Abstract
Background: Vitamin D deficiency has been associated with a multitude of disorders including diabetes, defective insulin secretion as well as rickets and poor bone health. Vitamin D is also a concern during childhood and adolescence and has been reported in girls from South Brazil. We determined the prevalence of vitamin D deficiency in girls from South Brazil and investigated whether the genotypic distribution of the BsmI, ApaI and TaqI polymorphisms of the VDR gene and their haplotypes were associated with vitamin D levels., Methods: Cross-sectional study including 234 apparently healthy girls aged 7 to 18 years. Height and weight were measured for calculation of body mass index (BMI) percentiles for age. Plasma levels of 25-hydroxyvitamin D [25(OH)D] were assessed. Participants were genotyped for ApaI (rs7975232), TaqI (rs731236), and BsmI (rs1544410) SNPs., Results: The median and interquartile range (25-75%) of BMI percentile was 62.0 (33.3 - 84.9). The frequency of overweight/obesity was 24.9%. Circulating levels of 25(OH)D (≥ 30 ng/mL) were adequate in 9.4%; insufficient in 54.3% (20-29 ng/mL); and deficient in 36.3% (< 20 ng/mL). Genotype frequencies were GG = 47.0%, GA = 41.5%, and AA = 11.5% for BsmI; GG = 16.7%, GT = 52.6%, and TT = 30.8% for ApaI; TT = 46.2%, TC = 44.9% and CC = 9.0% for TaqI. Genotypes with no gene variance (ancestral wild genotype) of BsmI (GG vs. GA + AA, two-tailed Student's t-test p < 0.001), ApaI (GG vs. GT + TT, two-tailed Student's t-test p = 0.031) and TaqI (TT vs. TC + CC, two-tailed Student's t-test p = 0.005) SNPs and the GGT haplotype (two-tailed Student's t-test p = 0.036) were significantly associated with lower 25(OH)D levels., Conclusions: 25-hydroxyvitamin D deficiency and insufficiency were highly prevalent in this sample. The BsmI, ApaI and TaqI wild variants of the VDR gene, as well as the GGT haplotype, were associated with lower vitamin D levels, suggesting that VDR gene polymorphisms could be linked to higher susceptibility to vitamin D deficiency in a sub-population of children and adolescents.
- Published
- 2012
- Full Text
- View/download PDF
23. [Assessment of diastolic function in children and adolescents with type 1 diabetes mellitus - are there early signs of diabetic cardiomyopathy?].
- Author
-
Santos CD, Souza AM, Pereira RM, Boguszewski MC, França SN, Vieira CG, Furuta M, and Lacerda Filho Ld
- Subjects
- Adolescent, Age Factors, Albuminuria blood, Body Mass Index, Child, Child, Preschool, Cross-Sectional Studies, Diastole physiology, Echocardiography, Doppler, Female, Humans, Male, Predictive Value of Tests, Regression Analysis, Sex Factors, Time Factors, Diabetes Mellitus, Type 1 physiopathology, Diabetic Cardiomyopathies physiopathology
- Abstract
Objectives: To evaluate diastolic function (DF) of children and adolescents with type 1 diabetes mellitus (DM1)., Subjects and Methods: Cross-sectional study of 67 otherwise healthy diabetic patients, and a control group (n = 84) in regard to age, sex, body mass index (BMI), Dopplere-chocardiography, and ECG for both groups; and disease duration, HbA1C, microalbuminuria, and serum lipids for DM 1 patients., Results: Diastolic alterations [(A and E mitral waves, E/A ratio, isovolumic relaxation time (IVRT) and E wave deceleration time (EWDT)] were found in diabetic patients, with higher prevalence among pubertal girls (13-17 years old). IVRT and EWDT correlated positively with BMI (p = 0.028). Chronological age and disease duration were predictive factors for mitral A wave (p = 0.004 and 0.033, respectively)., Conclusions: DF alterations were detected in the group of diabetic patients, with greater prevalence among pubertal girls; disease duration and age influenced parameters of DF.
- Published
- 2012
- Full Text
- View/download PDF
24. Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype.
- Author
-
Street ME, Spaggiari C, Ziveri MA, Rossi M, Volta C, Viani I, Grzincich GL, Sartori C, Zanzucchi M, Raia V, Terzi C, Pisi G, Zanetti E, Boguszewski MC, Kamoi TO, and Bernasconi S
- Subjects
- Adolescent, Adult, Age Factors, Body Mass Index, C-Peptide blood, Child, Cystic Fibrosis metabolism, Female, Genotype, Glucose Tolerance Test, Homeostasis physiology, Humans, Inflammation metabolism, Inflammation physiopathology, Insulin blood, Insulin-Secreting Cells physiology, Lung physiology, Male, Young Adult, Cystic Fibrosis genetics, Cystic Fibrosis physiopathology, Insulin biosynthesis, Insulin Resistance physiology
- Abstract
Aim: To assess the major determinants of glucose tolerance between age, genotype, and clinical status in cystic fibrosis (CF) patients, and study if defects of insulin secretion and insulin sensitivity were associated with the onset of CF-related diabetes (CFRD)., Subjects and Methods: One hundred and nineteen patients, in stable clinical condition were studied. They were subdivided into 3 groups based on age, and 2 groups based on Schwachman-Kulczycki clinical score. All patients were genotyped, and subsequently divided into 3 groups. Ninety-four healthy normal-weight controls, comparable for sex and age were also studied. All subjects had baseline blood samples taken for glucose and insulin, C-peptide, and glycated hemoglobin. Homeostasis model assessment of insulin resistance (HOMA-IR), fasting glucose/insulin ratio (FGIR) were calculated as indices of IR and insulinogenic index as a marker of pancreatic β-cell function. All patients underwent an oral glucose tolerance test, and 57 underwent an IVGTT for the calculation of first-phase (FPIR) and acute insulin responses (AIR)., Results: The F508del homozygous patients had an increased chance of developing impaired glucose tolerance (IGT) and significantly lower FPIR, decreased HOMA-IR, and insulinogenic index. Heterozygote F508del patients had an increased chance of having normal glucose tolerance. HOMA-IR, FGIR, and insulinogenic index did not change with age or clinical score. HOMAIR correlated with FPIR. FPIR correlated positively with insulinogenic index. AIR correlated negatively with FGIR, and positively with C-reactive protein. In multiple linear regression analyses, glucose tolerance was related to the agegroup, and to the HOMA-IR and insulinogenic indexes., Conclusions: IGT and CFRD were related mainly to genotype, although, as expected, the prevalence increased with age. The data suggested a possible combined contribution of insulin deficiency, β-cell function, and reduced insulin sensitivity to the onset of CFRD; however, further studies are warranted to better elucidate this aspect., (© 2012, Editrice Kurtis.)
- Published
- 2012
- Full Text
- View/download PDF
25. [Metabolic syndrome in adolescents of different nutritional status].
- Author
-
Stabelini Neto A, Bozza R, Ulbrich A, Mascarenhas LP, Boguszewski MC, and Campos Wd
- Subjects
- Adolescent, Brazil epidemiology, Chi-Square Distribution, Child, Female, Humans, Male, Metabolic Syndrome diagnosis, Prevalence, Reference Values, Risk Factors, Metabolic Syndrome epidemiology, Nutritional Status physiology, Obesity epidemiology
- Abstract
Objective: To investigate the prevalence of metabolic syndrome (MetS) in adolescents of different nutritional status., Subjects and Methods: The sample consisted of 582 adolescents aged 12 to 18 years. Body mass index (BMI) classification of nutritional status was performed using the NCHS growth charts. MetS diagnosis was determined by the presence of three or more risk factors., Results: Overall MetS prevalence was 6.7% (CI: 4.9%-9%); in boys, prevalence was 9.4%; and in girls, 4.1%. MetS prevalence was 17.2% (CI: 10%-28.2%) and 37.1% (CI: 23.2%-53.7%) in overweight and obese adolescents, respectively. All obese adolescents had at least one risk factor present, and demonstrated high MetS prevalence ratio compared with adolescents of normal weight (PR: 11.1; CI: 5.75-21.47)., Conclusion: High prevalence of MetS was observed in obese adolescents. Prevention strategies should focus on body weight control since the beginning of adolescence.
- Published
- 2012
- Full Text
- View/download PDF
26. GH-releasing hormone receptor gene: a novel splice-disrupting mutation and study of founder effects.
- Author
-
Marui S, Trarbach EB, Boguszewski MC, França MM, Jorge AA, Inoue H, Nishi MY, de Lacerda Filho L, Aguiar-Oliveira MH, Mendonca BB, and Arnhold IJ
- Subjects
- Adolescent, Brazil, Child, Child, Preschool, DNA Mutational Analysis, Dwarfism, Pituitary genetics, Female, Humans, Male, Founder Effect, Mutation, RNA Splice Sites genetics, RNA Splicing genetics, Receptors, Neuropeptide genetics, Receptors, Pituitary Hormone-Regulating Hormone genetics
- Abstract
Background: Mutations in GH-releasing hormone receptor gene (GHRHR) are emerging as the most common cause of autosomal recessive isolated GH deficiency (IGHD)., Objective: To search for GHRHR mutations in patients with familial or sporadic IGHD and to investigate founder effects in recurring mutations., Methods: The coding region of GHRHR was entirely amplified and sequenced from DNA of 18 patients with IGHD (16 unrelated) with topic posterior pituitary lobe on MRI. Haplotypes containing promoter SNPs and microsatellites flanking GHRHR were analyzed in patients with c.57+1G>A (IVS1+1G>A) mutation of our previously published kindred and also a Brazilian patient and 2 previously reported Japanese sisters with c.1146G>A (p.E382E) mutation., Results: A novel homozygous intronic GHRHR c.752-1G>A (IVS7-1G>A) mutation, predicting loss of the constitutive splice acceptor site, was identified in two siblings with IGHD. A compound heterozygous c.[57+1G>A];[1146G>A] and a heterozygous c.527C>T (p.A176V) were found in two sporadic cases. Haplotype analysis provided evidence for a founder effect for the c.57+1G>A mutation and independent recurrence for the c.1146G>A mutation., Conclusion: We report a novel splice-disrupting mutation in GHRHR in 2 siblings and provide evidence that all c.57+1G>A (IVS1+1G>A) mutant chromosomes have the same haplotype ancestor, indicating the occurrence of a founder effect in Brazilian patients with IGHD., (Copyright © 2012 S. Karger AG, Basel.)
- Published
- 2012
- Full Text
- View/download PDF
27. GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients.
- Author
-
Fideleff HL, Jonsson B, Koltowska-Häggström M, Boguszewski MC, Wilton P, and Boquete HR
- Subjects
- Adolescent, Adult, Age of Onset, Female, Humans, Male, Quality of Life, Regression Analysis, Hormone Replacement Therapy, Human Growth Hormone deficiency
- Abstract
Objective: To study two subsets of patients with GH deficiency (GHD) during the transition period: childhood onset GHD (CO-GHD) and patients who develop GHD during the transition phase (TO-GHD) before and after GH replacement., Patients and Measurements: In 1340 GHD subjects from KIMS (Pfizer International Metabolic Database), CO (n=586) or TO (n=754), background characteristics, anthropometric measurements, IGF-1, lipids and quality of life (QoL) were evaluated at baseline and after 3 years of GH replacement., Results: Both groups responded similarly to GH treatment. Changes of clinical outcomes were mainly determined by their value at baseline. Onset of the disease in childhood or transition period did not appear to be a significant predictor of response in any of the clinical outcomes., Conclusions: Age at GHD diagnosis was a significant predictor for many outcomes at baseline, but disease onset did not appear as an independent predictor concerning changes after 3 years of GH treatment. The results suggest that GH replacement during the transition period should be considered independently of the onset of the deficiency.
- Published
- 2012
- Full Text
- View/download PDF
28. [Growth of preterm-born children].
- Author
-
Cardoso-Demartini Ade A, Bagatin AC, Silva RP, and Boguszewski MC
- Subjects
- Adolescent, Child, Child, Preschool, Humans, Infant, Infant, Newborn, Reference Values, Young Adult, Body Height physiology, Growth Disorders etiology, Infant, Premature growth & development
- Abstract
Children born prematurely might experience a period of growth restriction just after birth. Catch-up growth begins during the first months of life and can be slow and progressive. These children may remain shorter and thinner throughout infancy and childhood compared to children born at term. In some cases, complete catch-up growth occurs only during adolescence. However, some children do not completely recover growth, and adults born prematurely are at increased risk of short stature. Impaired growth is more frequent in those born preterm and small for gestational age. Factors such as target height, birth weight, gestational age, neonatal morbidities and maternal education interfere in growth potential. Special attention should be given to children born preterm during the whole growth period.
- Published
- 2011
- Full Text
- View/download PDF
29. Physical activity, cardiorespiratory fitness, and metabolic syndrome in adolescents: a cross-sectional study.
- Author
-
Stabelini Neto A, Sasaki JE, Mascarenhas LP, Boguszewski MC, Bozza R, Ulbrich AZ, da Silva SG, and de Campos W
- Subjects
- Adolescent, Brazil epidemiology, Cross-Sectional Studies, Female, Humans, Male, Motor Activity, Prevalence, Risk Factors, Cardiovascular Diseases epidemiology, Exercise physiology, Metabolic Syndrome epidemiology, Physical Fitness
- Abstract
Background: In adults, there is a substantial body of evidence that physical inactivity or low cardiorespiratory fitness levels are strongly associated with the development of metabolic syndrome. Although this association has been studied extensively in adults, little is known regarding this association in adolescents. The aim of this study was to analyze the association between physical activity and cardiorespiratory fitness levels with metabolic syndrome in Brazilian adolescents., Methods: A random sample of 223 girls (mean age, 14.4 ± 1.6 years) and 233 boys (mean age, 14.6 ± 1.6 years) was selected for the study. The level of physical activity was determined by the Bouchard three-day physical activity record. Cardiorespiratory fitness was estimated by the Leger 20-meter shuttle run test. The metabolic syndrome components assessed included waist circumference, blood pressure, HDL-cholesterol, triglycerides, and fasting plasma glucose levels. Independent Student t-tests were used to assess gender differences. The associations between physical activity and cardiorespiratory fitness with the presence of metabolic syndrome were calculated using logistic regression models adjusted for age and gender., Results: A high prevalence of metabolic syndrome was observed in inactive adolescents (males, 11.4%; females, 7.2%) and adolescents with low cardiorespiratory fitness levels (males, 13.9%; females, 8.6%). A significant relationship existed between metabolic syndrome and low cardiorespiratory fitness (OR, 3.0 [1.13-7.94])., Conclusion: The prevalence of metabolic syndrome is high among adolescents who are inactive and those with low cardiorespiratory fitness. Prevention strategies for metabolic syndrome should concentrate on enhancing fitness levels early in life.
- Published
- 2011
- Full Text
- View/download PDF
30. Latin American consensus: children born small for gestational age.
- Author
-
Boguszewski MC, Mericq V, Bergada I, Damiani D, Belgorosky A, Gunczler P, Ortiz T, Llano M, Domené HM, Calzada-León R, Blanco A, Barrientos M, Procel P, Lanes R, and Jaramillo O
- Subjects
- Child, Preschool, Diabetes Mellitus, Type 2 etiology, Dose-Response Relationship, Drug, Dyslipidemias etiology, Female, Growth Disorders complications, Growth Disorders etiology, Human Growth Hormone therapeutic use, Humans, Hyperandrogenism etiology, Hypertension etiology, Hypoglycemic Agents therapeutic use, Infant, Infant, Low Birth Weight, Infant, Newborn, Insulin Resistance, Latin America epidemiology, Male, Metformin therapeutic use, Puberty, Reference Values, Risk Factors, Growth Disorders drug therapy, Infant, Small for Gestational Age growth & development
- Abstract
Background: Children born small for gestational age (SGA) experience higher rates of morbidity and mortality than those born appropriate for gestational age. In Latin America, identification and optimal management of children born SGA is a critical issue. Leading experts in pediatric endocrinology throughout Latin America established working groups in order to discuss key challenges regarding the evaluation and management of children born SGA and ultimately develop a consensus statement., Discussion: SGA is defined as a birth weight and/or birth length greater than 2 standard deviations (SD) below the population reference mean for gestational age. SGA refers to body size and implies length-weight reference data in a geographical population whose ethnicity is known and specific to this group. Ideally, each country/region within Latin America should establish its own standards and make relevant updates. SGA children should be evaluated with standardized measures by trained personnel every 3 months during year 1 and every 6 months during year 2. Those without catch-up growth within the first 6 months of life need further evaluation, as do children whose weight is ≤ -2 SD at age 2 years. Growth hormone treatment can begin in SGA children > 2 years with short stature (< -2.0 SD) and a growth velocity < 25th percentile for their age, and should continue until final height (a growth velocity below 2 cm/year or a bone age of > 14 years for girls and > 16 years for boys) is reached. Blood glucose, thyroid function, HbA1c, and insulin-like growth factor-1 (IGF-1) should be monitored once a year. Monitoring insulin changes from baseline and surrogates of insulin sensitivity is essential. Reduced fetal growth followed by excessive postnatal catch-up in height, and particularly in weight, should be closely monitored. In both sexes, gonadal function should be monitored especially during puberty., Summary: Children born SGA should be carefully followed by a multidisciplinary group that includes perinatologists, pediatricians, nutritionists, and pediatric endocrinologists since 10% to 15% will continue to have weight and height deficiency through development and may benefit from growth hormone treatment. Standards/guidelines should be developed on a country/region basis throughout Latin America.
- Published
- 2011
- Full Text
- View/download PDF
31. Growth hormone treatment in short children born prematurely--data from KIGS.
- Author
-
Boguszewski MC, Karlsson H, Wollmann HA, Wilton P, and Dahlgren J
- Subjects
- Child, Child, Preschool, Female, Humans, Male, Treatment Outcome, Body Height physiology, Growth Disorders therapy, Human Growth Hormone therapeutic use, Premature Birth
- Abstract
Context: Children born prematurely with growth failure might benefit from GH treatment., Objectives: The aim was to evaluate the first year growth response to GH treatment in short children born prematurely and to identify predictors of the growth response., Design/patients: A total of 3215 prepubertal children born prematurely who were on GH treatment were selected from KIGS (The Pfizer International Growth Database), a large observational database. They were classified according to gestational age as preterm (PT; 33 to no more than 37 wk) and very preterm (VPT; <33 wk), and according to birth weight as appropriate for gestational age [AGA; between -2 and +2 sd score (SDS)] and small for gestational age (SGA; -2 SDS or below)., Results: Four groups were identified: PT AGA (n = 1928), VPT AGA (n = 629), PT SGA (n = 519), and VPT SGA (n = 139). GH treatment was started at a median age of 7.5, 7.2, 6.7, and 6.0 yr, respectively. After the first year of GH treatment, all four groups presented a significant increase in weight gain and height velocity, with a median increase in height SDS higher than 0.6. Using multiple stepwise regression analysis, 27% of the variation in height velocity could be explained by the GH dose, GH peak during provocative test, weight and age at GH start, adjusted parental height, and birth weight SDS. The first year growth response of the children born PT and SGA could be estimated by the SGA model published previously., Conclusion: Short children born prematurely respond well to the first year of GH treatment. Long-term follow-up is needed.
- Published
- 2011
- Full Text
- View/download PDF
32. [Final height (FH) in Turner syndrome (TS): experience of 76 cases followed at the Pediatric Endocrinology Unit, Hospital de Clinicas, Federal University of Paraná].
- Author
-
Fonteles AV, Dondoni RS, Boguszewski MC, Nesi-França S, Marques-Pereira R, Sandrini Neto R, and Lacerda Filho Ld
- Subjects
- Adolescent, Age Determination by Skeleton, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Oxandrolone therapeutic use, Puberty physiology, Regression Analysis, Treatment Outcome, Turner Syndrome diagnosis, Androgens therapeutic use, Body Height drug effects, Estrogens therapeutic use, Human Growth Hormone therapeutic use, Progestins therapeutic use, Turner Syndrome drug therapy
- Abstract
Objective: To report the final height (FH) of 76 patients with Turner syndrome (TS)., Materials and Methods: Review of the files and calculation of z scores: of target height (TH), and FH according to NCHS/CDC/2000 and FH according to Lyon and cols., Results: Patients were classified in three groups: A (n = 16), treatment with estrogens and progestogens; B (n = 21), treatment with oxandrolone (OX); C (n = 39), growth hormone (GH) plus OX. The z score of TH was not different among the groups and z score of FH was not different between A e B. Z score of FH of group C was greater than the other groups, > 2SDS of Lyon's curve and fitted on the 3(rd) percentile of NCHS/CDC. Multiple regression analysis showed type of treatment (p < 0.001) and maternal height (p = 0.02) as most influencing factors on FH., Conclusion: GH plus OX and maternal height contributed significantly to enhance FH of TS patients.
- Published
- 2011
- Full Text
- View/download PDF
33. Short children born prematurely: data from KIGS.
- Author
-
Boguszewski MC, Karlsson H, and Wilton P
- Subjects
- Child, Databases, Factual, Growth Disorders drug therapy, Human Growth Hormone therapeutic use, Humans, Infant, Newborn, Body Height physiology, Infant, Premature growth & development, Infant, Small for Gestational Age growth & development
- Abstract
Background: Advances in neonatal care have enabled the survival of extremely preterm infants. Some of them have growth failure and remain short at later ages. As a consequence, children born prematurely may be candidates for growth hormone (GH) treatment., Aims: The goal of this study was to obtain information about children on GH therapy enrolled in the Pfizer International Growth Database (KIGS) who were born prematurely., Patients: The KIGS database was queried for data on prepubertal short children (height <-2 standard deviation score; SDS) born with gestational age below 37 weeks. Birth weight had to be available., Results: In total, 3,215 patients were selected and classified according to gestational age and birth weight as preterm (<37 weeks' gestation), very preterm (VP; <33 weeks' gestation), appropriate for gestational age (AGA; birth weight between -2 and +2 SDS) or small for gestational age (SGA; birth weight <-2 SDS). Of these, 1,928 children were preterm AGA, 629 very preterm AGA, 519 preterm SGA, and 139 very preterm SGA., Conclusions: KIGS is a cumulative database and provides a unique opportunity to evaluate the growth response to GH therapy of premature children born with differences in gestational ages, size at birth, rate of postnatal growth, and GH secretion status., (Copyright © 2011 S. Karger AG, Basel.)
- Published
- 2011
- Full Text
- View/download PDF
34. Physical activity in children with type 1 diabetes.
- Author
-
Miculis CP, Mascarenhas LP, Boguszewski MC, and Campos Wd
- Subjects
- Adolescent, Child, Humans, Diabetes Mellitus, Type 1 metabolism, Hypoglycemia prevention & control, Motor Activity physiology, Sports physiology
- Abstract
Objective: To discuss the practical aspects of safe physical activity and sports participation in children and adolescents with type 1 diabetes mellitus., Sources: A literature search was conducted using national (SciELO) and international (PubMed/MEDLINE) databases and the reference lists of the articles found, adopting the following limits: articles on physical activity published in the last 10 years, preferably conducted in children and adolescents with type 1 diabetes. Most studies had an experimental design or were meta-analyses., Summary of the Findings: Skeletal muscle glucose uptake is greater during aerobic metabolism in order to generate energy for muscle contraction, which suppresses hepatic gluconeogenesis and thus promotes a decrease in blood glucose levels and increased risk of hypoglycemia. Adequate carbohydrate replacement before, during, and after exercise and reduction of preprandial rapid-acting insulin doses are the main allies in avoiding severe hypoglycemic events among diabetic children and adolescents., Conclusions: Type, duration, and intensity of physical activity must be considered when planning carbohydrate replacement and insulin dose reduction, as must the timing of exercise. Nonetheless, physical activity and participation in many individual and team sports is possible and highly recommended in the treatment of type 1 diabetes in children and adolescents.
- Published
- 2010
- Full Text
- View/download PDF
35. [Small for gestational age infants: need for medical follow-up during all the period of growth].
- Author
-
Boguszewski MC
- Subjects
- Humans, Infant, Newborn, Growth Hormone therapeutic use, Infant, Small for Gestational Age growth & development
- Published
- 2010
- Full Text
- View/download PDF
36. [Atherosclerotic risk factors associated with cardiorespiratory fitness and BMI in adolescents].
- Author
-
Stabelini Neto A, Bozza R, Ulbrich AZ, Vasconcelos IQ, Mascarenhas LP, Boguszewski MC, and de Campos W
- Subjects
- Adolescent, Atherosclerosis diagnosis, Blood Pressure physiology, Child, Cholesterol blood, Female, Humans, Logistic Models, Male, Risk Factors, Triglycerides blood, Atherosclerosis etiology, Body Mass Index, Oxygen Consumption physiology, Physical Fitness physiology
- Abstract
Previous research has demonstrated high prevalence of atherosclerotic risk factors in adolescents; however, the associate factors related to its onset are unclear. Therefore, the objective of this study was to relate inadequate blood pressure levels, total cholesterol (TC), HDL-C, LDL-C and triglycerides (TG) with different VO2máx and BMI levels in a sample of 249 adolescents, aged between 12 to 16 years old. For VO2máx prediction, the 20 meters test was used. The BMI was calculated using the body mass/heigh(2) equation. The considerate inadequate levels were: blood pressure > or =90th percentile; total cholesterol > or =150 mg/dL; LDL-C > or = 100 mg/dL, TG > or =100 mg/dL and HDL-C <45 mg/dL. Logistic regression was used as statistical procedures, with p<0.05. For the boys, significant associations were observed between the low VO2máx with TC (OR 4.33; IC=1.23-15.20) and TG (OR=4.88; IC=1.15-20.79) and between overweight and TG (OR=4.33; IC=1.42-13.21). After BMI correction, the males subjects with low VO2máx maintained their significant associations with TC (OR=5.73; IC=1.52-21.58) and TG (OR=3.81; IC=1.86-16.94). The evidences in this study suggested an inverse relationship of the cardiorespiratory fitness with TC and TG for boys, independently of the BMI.
- Published
- 2008
- Full Text
- View/download PDF
37. [Growth hormone therapy for children with chronic diseases].
- Author
-
Barreto AM, Bigolin MC, Ramos JC, Machado LP, Silva Ldos R, Silveira RB, and Boguszewski MC
- Subjects
- Body Height drug effects, Child, Chronic Disease, Cytokines physiology, Dwarfism drug therapy, Dwarfism etiology, Growth Disorders etiology, Humans, Growth Disorders drug therapy, Human Growth Hormone therapeutic use, Inflammatory Bowel Diseases complications, Inflammatory Bowel Diseases physiopathology
- Abstract
Growth disorders are commonly observed in children suffering from chronic diseases. The pathogenesis of growth failure is multifactorial. In chronic inflammatory diseases such as juvenile idiopathic arthritis and inflammatory bowel disease, growth is also affected by pro-inflammatory cytokines. Patients with chronic diseases might also become growth hormone (GH) deficient. However, normal or increased GH secretion with reduced plasma concentrations of insulin-like growth factor-I indicate a degree of GH insensitivity in some patients. Growth damage can increase with specific treatments, especially if glucocorticoids are used. GH therapy has been used to reduce the consequences of the disease and long-term steroid therapy in these patients. In this review, it is reported the encouraging results of GH treatment in growth-retarded children with chronic diseases, both in well defined indications as well in situations still under investigation.
- Published
- 2008
- Full Text
- View/download PDF
38. [Growth hormone therapy for short children born small for gestational age].
- Author
-
Boguszewski MC and Boguszewski CL
- Subjects
- Child, Human Growth Hormone blood, Humans, Infant, Newborn, Insulin-Like Growth Factor I analysis, Lipid Metabolism drug effects, Body Height drug effects, Human Growth Hormone therapeutic use, Infant, Small for Gestational Age growth & development
- Abstract
Approximately 10% of all children born small for gestational age (SGA) fail to achieve sufficient catch-up growth and remain with short stature throughout childhood and adult life. Abnormalities of the GH/IGF-1 axis are not always identified. Several studies have demonstrated that GH is an effective and well-tolerated therapy and most children will reach a normal adult height. In this review, it can be seen the encouraging results of GH treatment in growth-retarded children born SGA highlighting the benefits of early treatment.
- Published
- 2008
- Full Text
- View/download PDF
39. [Transient neonatal hypothyroidism due to amiodarone administration during pregnancy--two cases report and review of literature].
- Author
-
Pavan-Senn CC, Nesi-França S, Pelaez J, Pereira RM, Boguszewski MC, Sandrini Neto R, and Lacerda Filho Ld
- Subjects
- Cognition Disorders diagnosis, Congenital Hypothyroidism psychology, Female, Humans, Infant, Newborn, Intelligence, Pregnancy, Thyroid Function Tests, Thyroid Gland drug effects, Amiodarone adverse effects, Anti-Arrhythmia Agents adverse effects, Cognition Disorders etiology, Congenital Hypothyroidism chemically induced
- Abstract
Introduction: Amiodarone (AMD) is an antiarrhythmic agent which contains 37% of iodine. It can reach the fetus by transplacental passage and induce transient congenital hypothyroidism (TCH). We report two cases of TCH caused by gestational exposure to AMD, detected by the Newborn Screening Program for Congenital Hypothyroidism of the State of Paraná-Brazil. CLINICAL CASE 1 (C1): Neonatal TSH value was 78.2 mU/L (normal<15 mU/L). AMD had been given to the mother during pregnancy to treat maternal arrhythmia. The screening results were confirmed by serum thyroid function tests. Levothyroxin (L-T4) (50 microg/day) was started on the first visit, on the 14th day of life (dl). CLINICAL CASE 2 (C2): Neonatal TSH value was 134.0 mU/L. AMD had been given to the mother in the third trimester of pregnancy to treat maternal arrhythmia. The screening results were confirmed by serum thyroid function tests: L-T4 (50 microg/day) was started on the first visit, with 13 dl., Follow-Up: TSH and T4 normalized on 51 dl (C1) and 36 dl (C2); L-T4 could be diminished gradually and stopped within 16 months (C1) and 10 months (C2). They were followed-up until 22 months (C1) and 16 months (C2) with normal thyroid function tests. Their growth and mental development, evaluated by the Cognitive Adaptive Test/Clinical Linguistic & Auditory Milestone Scale (CAT/CLAMS test), were normal., Conclusion: Evaluation of thyroid function and mental development should be performed if AMD is used during pregnancy. Treatment of TCH must be started as soon as the diagnosis is made.
- Published
- 2008
- Full Text
- View/download PDF
40. Polymorphisms identified in the upstream core polyadenylation signal of IGF1 gene exon 6 do not cause pre- and postnatal growth impairment.
- Author
-
Coutinho DC, Coletta RR, Costa EM, Pachi PR, Boguszewski MC, Damiani D, Mendonca BB, Arnhold IJ, and Jorge AA
- Subjects
- 3' Untranslated Regions genetics, Alleles, Child, DNA genetics, Exons genetics, Female, Genotype, Humans, Infant, Newborn, Male, Polymorphism, Genetic genetics, Signal Transduction genetics, Growth Disorders genetics, Infant, Small for Gestational Age physiology, Insulin-Like Growth Factor I genetics, Polyadenylation genetics
- Abstract
Background: Few children born small for gestational age (SGA) with IGF1 mutations have been reported. One of these patients presented a mutation at 3' untranslated region (UTR) at exon 6, probably affecting the polyadenylation process., Objective: The objective of the study was to sequence the IGF1 gene of children born SGA., Patients and Methods: IGF1 (exons 1-6) was directly sequenced in 53 SGA children without catch-up growth. Allelic variant frequency of the identified IGF1 polymorphisms was assessed in a total of 145 SGA children and in 180 controls born with adequate weight and length and adult height sd score greater than -2., Results: No mutations were identified in the IGF1 coding regions in SGA children. In contrast, six allelic variants were identified in the upstream core polyadenylation signal located in IGF1 3' UTR at exon 6. The frequency of the different allelic variants was similar in SGA children and controls. It is noteworthy that the same allelic variant, previously described as causing severe IGF1 deficiency, was also observed in homozygous (n = 4) and heterozygous state (n = 6) in normal height controls, corresponding to 4% of studied alleles. The three most frequently identified allelic variants of IGF1 3' UTR showed no effect on height sd score of adult controls as well as on birth characteristics in SGA children., Conclusion: The polymorphisms identified in the upstream core polyadenylation signal at IGF1 exon 6 do not cause IGF1 deficiency as well as pre- and postnatal growth impairment, in contrast to previously reported data.
- Published
- 2007
- Full Text
- View/download PDF
41. Insulin-like growth factor-1, leptin, body composition, and clinical status interactions in children with cystic fibrosis.
- Author
-
Boguszewski MC, Kamoi TO, Bento Radominski R, Boguszewski CL, Rosberg S, Filho NA, Sandrini Neto R, and Albertsson-Wikland K
- Subjects
- Adipose Tissue anatomy & histology, Adolescent, Biomarkers blood, Child, Child Development, Child, Preschool, Cross-Sectional Studies, Female, Humans, Inflammation blood, Male, Body Composition, Cystic Fibrosis blood, Insulin-Like Growth Factor I analysis, Leptin blood
- Abstract
Background/aims: Children with cystic fibrosis (CF) are of increased risk of reduced fat body mass (FBM) and lean body mass (LBM). Serum concentrations of insulin-like growth factor-1 (IGF-1)and leptin could be markers of LBM and/or FBM depletion. To evaluate the relationships between disease activity, body composition, IGF-1 and leptin concentrations in CF children., Methods: A cross-sectional study with 26 CF children aged 5.0-15.5 years and 33 healthy controls, mean age 9.4 years. Body composition was evaluated by dual-energy X-ray absorptiometry. Fasting blood samples were analyzed for leptin, IGF-1 and IGFBP-3., Results: FBM standard deviation score (SDS; CF boys -0.02 +/- 0.88 vs. 0.78 +/- 0.65, p < 0.01; CF girls -0.37 +/- 1.15 vs. 0.70 +/- 0.97, p < 0.05), leptin concentration (CF boys 2.07 +/- 0.79 vs. 3.07 +/- 1.28 ng/ml, p < 0.05; CF girls 2.71 +/- 0.86 vs. 5.00 +/- 2.95 ng/ml, p < 0.05) and IGF-1SDS (CF boys -1.43 +/- 1.50 vs. -0.32 +/- 0.88, p < 0.05; CF girls -0.66 +/- 1.66 vs. 0.64 +/- 0.57, p < 0.01) were lower in CF children compared to controls. Shwachman score was the strongest predictor of lean body mass (R = 0.63). Leptin levels explain 60% of the variability in FBM., Conclusion: Serum concentrations of IGF-1 and leptin are decreased in children with CF and are associated with clinical conditions and body composition., (Copyright (c) 2007 S. Karger AG, Basel.)
- Published
- 2007
- Full Text
- View/download PDF
42. [Treatment of childhood adrenocortical tumor].
- Author
-
Pereira RM, Michalkiewicz E, Pianovski MA, França SN, Boguszewski MC, Cat I, Lacerda Filho Ld, and Sandrini R
- Subjects
- Antineoplastic Combined Chemotherapy Protocols therapeutic use, Child, Child, Preschool, Combined Modality Therapy, Female, Humans, Infant, Male, Neoplasm Staging, Prognosis, Survival Analysis, Adrenal Cortex Neoplasms drug therapy, Adrenal Cortex Neoplasms surgery, Adrenocortical Carcinoma drug therapy, Adrenocortical Carcinoma surgery
- Abstract
Adrenocortical tumors (ACT) in children are uncommon. However, the incidence of these tumors in Paraná is 15 times higher than that worldwide. A germline mutation, R337H TP53, present in more than 95% of our patients, is probably the reason for the higher incidence in our state. A hundred twenty-five patients were treated in the period of 1966 to 2003. Surgery is the only curative treatment. In our experience, disease stage I, absence of spillage during surgery and absence of intravenous thrombus are associated with better survival rates. Preliminary data with the combination of etoposide, doxorubicin, cisplatin, and mitotane have shown that in some patients a complete remission is observed both of the tumor and metastasis. Side effects due to these drugs are common and adrenal insufficiency may occur. Glucocorticoid and mineralocorticoid reposition should be done with 2 to 3 times the physiological doses.
- Published
- 2005
- Full Text
- View/download PDF
43. [Childhood adrenocortical tumors].
- Author
-
Pereira RM, Michalkiewicz E, Sandrini F, Figueiredo BC, Pianovski M, França SN, Boguszewski MC, Costa O, Cat I, Lacerda Filho Ld, and Sandrini R
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Female, Humans, Infant, Male, Prognosis, Adrenal Cortex Neoplasms diagnosis, Adrenal Cortex Neoplasms therapy
- Abstract
Adrenocortical tumors (ACT) in children are uncommon. However, the incidence of these tumors in Paraná, Brazil, is 15 times higher than that worldwide. We describe the clinical, laboratory and treatment characteristics and outcome of 125 patients treated in a single institution in the State of Paraná. The median age at diagnosis was 4.3 years, with a female:male ratio of 2.6:1. The most common forms of presentation were isolated virilization (51.2%) and virilization and Cushing's syndrome (42%). Nonfunctioning tumors comprised 4.8% of the cases. Two patients (1.6%) had isolated Cushing's syndrome and 1 (0.8%) had Conn's syndrome. Fifty-six percent presented hypertension. Surgery is the only curative treatment. Our data show that disease stage 1, absence of spillage during surgery and absence of intravenous thrombus were associated with better survival rates.
- Published
- 2004
- Full Text
- View/download PDF
44. Low birth size and final height predict high sympathetic nerve activity in adulthood.
- Author
-
Boguszewski MC, Johannsson G, Fortes LC, and Sverrisdóttir YB
- Subjects
- Adult, Cardiovascular Diseases mortality, Cardiovascular Diseases physiopathology, Cross-Sectional Studies, Female, Gestational Age, Humans, Infant, Newborn, Male, Risk Factors, Body Height, Cardiovascular Diseases etiology, Infant, Low Birth Weight, Sympathetic Nervous System physiopathology
- Abstract
Objective: Being born small for gestational age (SGA) is associated with insulin resistance, hypertension and increased cardiovascular morbidity/mortality in adulthood. Sympathetic nerve hyperactivity is a well-known risk factor for cardiovascular disease mortality and is proposed to link insulin resistance with hypertension. The objective of this study was to test the hypothesis that sympathetic nerve activity is altered in individuals born SGA., Design: A cross-sectional, comparative study of 20 healthy adults (21-25 years old) born SGA (birth weight < -2SD score for healthy newborns) with normal and short stature, and 12 age, gender and body mass index matched individuals, born appropriate for gestational age (AGA) with normal stature., Methods: Direct recordings of resting sympathetic nerve activity to the muscle vascular bed (MSA) were obtained from the peroneal nerve posterior to the fibular head. Heart rate, respiration and blood pressure were recorded during the microneurographic session., Results: MSA was increased in both groups of young adults born SGA as compared to those born AGA (P < 0.05 and P < 0.005, respectively). In the combined study group MSA was inversely correlated to birth weight, length (r = -0.59, P < 0.001 and r = -0.69, P < 0.0005, respectively) and final adult height (r = -0.58; P < 0.001)., Conclusions: Being born SGA and achieving a short final height is associated with increased sympathetic nerve traffic. We suggest that the increase in sympathetic nerve traffic in young adults born SGA with normal and short stature may be the link between low birth size, hypertension and cardiovascular morbidity later in life.
- Published
- 2004
- Full Text
- View/download PDF
45. Serum leptin in short children born small for gestational age: dose-dependent effect of growth hormone treatment.
- Author
-
Boguszewski MC, de Zegher F, and Albertsson-Wikland K
- Subjects
- Belgium, Body Height, Body Weight, Child, Child, Preschool, Female, Human Growth Hormone therapeutic use, Humans, Infant, Newborn, Male, Sweden, Human Growth Hormone administration & dosage, Infant, Small for Gestational Age, Leptin analysis
- Abstract
Objective: To study the effects of different regimens of growth hormone (GH) treatment on serum leptin levels in 78 short prepubertal children born small for gestational age (SGA)., Methods: The children were originally included in two independent multicenter trials, one in Belgium and one in the Nordic countries. SGA children were randomized either to remain untreated or to be treated with GH at a daily dose of 0.1, 0.2 or 0.3 IU/kg for 2 years. Thereafter, treatment was continued for another 2 years in the Nordic children, whereas it was discontinued in the Belgian children., Results: In the GH treatment groups, a significant dose-dependent decrease in leptin levels was found during the first year of therapy, with a mean decrease of 13, 23 and 32% in the groups receiving GH at 0.1, 0.2 and 0.3 IU/kg, respectively. When high-dose treatment was interrupted, serum leptin increased within 1 year to pretreatment levels., Conclusion: Serum leptin levels in short children born SGA are transiently reduced by GH treatment in a dose-dependent fashion. The most pronounced changes in serum leptin were documented within the first year after initiation and withdrawal of high-dose GH treatment., (Copyright 2001 S. Karger AG, Basel)
- Published
- 2000
- Full Text
- View/download PDF
46. In vitro and in vivo responses to short-term recombinant human insulin-like growth factor-1 (IGF-I) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene.
- Author
-
de Lacerda L, Carvalho JA, Stannard B, Werner H, Boguszewski MC, Sandrini R, Malozowski SN, Leroith D, and Underwood LE
- Subjects
- Blotting, Southern, Cells, Cultured, Child, Preschool, Female, Fibroblasts drug effects, Fibroblasts metabolism, Growth Disorders drug therapy, Growth Disorders metabolism, Growth Hormone blood, Humans, Insulin-Like Growth Factor I metabolism, RNA, Messenger analysis, Receptor, IGF Type 1 metabolism, Recombinant Proteins metabolism, Recombinant Proteins therapeutic use, Chromosomes, Human, Pair 15, Gene Deletion, Growth Disorders genetics, Insulin-Like Growth Factor I therapeutic use, Receptor, IGF Type 1 genetics, Ring Chromosomes
- Abstract
Objectives: Patients with single allele defects in the gene encoding the type 1 IGF receptor have been reported to have growth failure, but fibroblasts from affected patients have not exhibited insensitivity to the effects of IGF-I in vitro. The in vitro and in vivo responses to short-term recombinant human IGF-I (rhIGF-I) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene have been investigated., Design and Patient: The child exhibited prenatal and severe post-natal growth failure, and delayed psychomotor development. Southern blotting revealed a 50% reduction in IGF-I receptor DNA, and in an RNase protection assay (RPA), a quantitatively similar reduction in steady-state mRNA for type 1 IGF receptor. rhIGF-I was administered in graded doses of 40, 60 and 80 microg/kg twice daily by subcutaneous injection for periods of 2-2.5 days each., Results: During rhIGF-I treatment, mean urinary nitrogen excretion was unchanged and urinary calcium rose to 60% greater than in the pre-treatment period. rhIGF-I injections produced only a modest decrease in indices of GH secretion, assessed by frequent (every 20 min) sampling over periods of 12 h. There was no significant difference between the mean GH concentrations during rhIGF-I treatment (5.32 +/- 6.2 mU/l) compared with that before rhIGF-I treatment (8.46 +/- 10.2 mU/l). Mean IGFBP-3-values were increased (4.5 mg/l before vs. 5.4 mg/l during rhIGF-I). TSH values after injection of TRH were not significantly reduced by IGF-I (mean of all values, 18.6 mU/l vs. 15.5 mU/l during rhIGF-I treatment). In vitro binding of radiolabelled IGF-I to the patient's fibroblasts was less than that bound by control fibroblasts (patient, 0.69% binding by 248 000 cells, vs. 1.41% binding by 260 000 fibroblasts from an age-matched control). However, the patient's fibroblasts exhibited a growth response in vitro to the addition of IGF-I in a fashion similar to that of control fibroblasts., Conclusions: These studies show evidence in each of the indices examined of in vivo resistance to IGF-I and suggest that the growth retardation observed in such patients may be the direct result of the absence of one of the alleles encoding the type 1 IGF receptor.
- Published
- 1999
- Full Text
- View/download PDF
47. Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure.
- Author
-
Boguszewski CL, Jansson C, Boguszewski MC, Rosberg S, Carlsson B, Albertsson-Wikland K, and Carlsson LM
- Subjects
- Adolescent, Child, Child, Preschool, Developmental Disabilities blood, Female, Human Growth Hormone chemistry, Humans, Infant, Newborn, Infant, Small for Gestational Age blood, Isomerism, Male, Molecular Weight, Osmolar Concentration, Sex Characteristics, Turner Syndrome blood, Body Height, Child Development, Human Growth Hormone blood
- Abstract
Current knowledge about the interaction between GH and its receptor suggests that the molecular heterogeneity of circulating GH may have important implications for growth. The aim of this study was to investigate the proportion of circulating non-22-kDa GH isoforms in prepubertal children with short stature (height less than -2 SD score) of different etiologies. We have also evaluated the relationships among the ratio of non-22-kDa GH isoforms, auxology, and spontaneous GH secretion. The study groups consisted of 17 girls with Turner's syndrome (TS), aged 3-13 yr, 25 children born small for gestational age (SGA) without postnatal catch-up growth, aged 3-13 yr; and 24 children with idiopathic short stature (ISS), aged 4-15 yr. The results were compared with those from 23 prepubertal healthy children of normal stature (height +/- 2 SD score), aged 4-13 yr. Serum non-22-kDa GH levels, expressed as a percentage of the total GH concentration, were determined by the 22-kDa GH exclusion assay, which is based on immunomagnetic extraction of monomeric and dimeric 22-kDa GH from serum and quantitation of non-22-kDa GH using a polyclonal antibody-based GH assay. All samples were selected from spontaneous GH peaks in 24-h GH profiles. The median proportion of non-22-kDa GH isoforms was increased in children born SGA (9.8%; P = 0.05) and girls with TS (9.9%; P = 0.01), but not in the group of children with ISS (8.9%), compared with that in normal children (8.1%). Individually, increased proportions of non-22-kDa GH isoforms, with values more than 2 SD above the mean for the normal group, were observed in 5 girls with TS, 5 children born SGA, and 4 children with ISS. In children born SGA, the proportion of non-22-kDa GH isoforms was directly correlated with different estimates of spontaneous GH secretion [mean 24-h GH concentration (r = 0.41; P = 0.04), area under the curve over baseline (r = 0.41; P = 0.04), and GH peak area (r = 0.61; P = 0.003)], whereas it was inversely correlated with height SD score (r = -0.42; P = 0.04). In conclusion, an increased proportion of circulating non-22-kDa GH isoforms was observed at spontaneous GH peaks in some non-GH-deficient short children. Our results suggest that the ratio of non-22-kDa GH isoforms in the circulation may have important implications for normal and abnormal growth.
- Published
- 1997
- Full Text
- View/download PDF
48. A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene.
- Author
-
Medeiros-Neto G, Herodotou DT, Rajan S, Kommareddi S, de Lacerda L, Sandrini R, Boguszewski MC, Hollenberg AN, Radovick S, and Wondisford FE
- Subjects
- Base Sequence, Female, Humans, Male, Molecular Sequence Data, Polymerase Chain Reaction, Thyrotropin blood, Congenital Hypothyroidism, Mutation, Thyrotropin genetics
- Abstract
Mutation of a critical carboxy-terminal cysteine residue (C105V) in the thyrotropin-beta (TSH-beta) subunit gene was found in two related families with central hypothyroidism. Affected patients had low thyroid hormone levels and radioactive iodine uptake in the thyroid gland associated with measurable serum TSH. Thyrotropin-releasing hormone-stimulated TSH secretion did not increase thyroid hormone production in these patients as compared to their unaffected siblings, suggesting that the mutant TSH was biologically inactive in vivo. Recombinant TSH harboring this mutation was confirmed to be biologically inactive in an in vitro bioassay. Based on crystallographic structure of chorionic gonadotropin, a disulfide bond between C19 and C105 in the TSH-beta subunit is predicted to form the "buckle" of a "seat belt" that surrounds the common alpha subunit and maintains the conformation and bioactivity of the hormone. This natural mutation of the TSH-beta subunit confirms the importance of the seat belt in the family of pituitary and placental glycoprotein hormones.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.